FDA D.I.S.C.O. Burst Edition: FDA approvals of Augtyro (repotrectinib) for NTRK gene fusion-posit...
59:45
Clinicians Connect: Conversations w/ FDA's CMO on reducing cases of congenital syphilis & syphilis
27:26
Improving the Quality of Life for People with Sickle Cell Disease
1:57:53
Clinical Pharmacology Considerations for Novel Therapeutic Modalities
12:34
Toward Improving Race and Ethnicity Data in Health Care
1:00:02
Ovarian Cancer: Moving to a Personalized Treatment Approach
4:01
FDA D.I.S.C.O. Burst Edition: FDA approval of Retevmo (selpercatinib) for advanced or metastatic ...
32:43
FDA Webinar on Allergen Labeling for Retail Food Stores and Food Service Establishments
51:23